Translational Oncology

Article	Citations
ERβ-regulated circATP2B1/miR-204–3p/TWIST1 positive feedback loop facilitates epithelial to mesenchymal transition in clear cell renal cell carcinoma	144
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma	126
Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer	122
Corrigendum to “Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer” [Translational Oncology 44 (2024) 1–10/101923]	99
Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma	82
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer	80
Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data	77
Comment on: AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario	76
68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors	71
A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways	67
LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification	67
Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency	56
Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors	56
Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers	53
NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation	52
Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate	52
Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics	50
Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy	49
OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis	46
Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis	46
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma	44
The Potential Role of C4 MYH11+ Fibroblasts and the MDK-SDC2 Ligand-Receptor Pair in Lung Adenocarcinoma: Implications for Prognosis and Therapeutic Strategies	42
Investigating the molecular mechanisms and clinical potential of APO+ endothelial cells associated with PANoptosis in the tumor microenvironment of hepatocellular carcinoma using single-cell sequencin	41
A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma	40
The double face of cold in cancer	40

Radiation from frequent whole-body CT scans induces systemic immunosuppression and immune activation of tumor tissue	40
Commentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma	39
FUBP1 in human cancer: Characteristics, functions, and potential applications	39
Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer	38
Predicting lymphoma prognosis using machine learning-based genes associated with lactylation	38
Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer	38
miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway	37
GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation	35
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant	35
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations	34
Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer	34
CDYL loss promotes cervical cancer aggression by increasing PD-L1 expression via the suppression of IRF2BP2 transcription	34
CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells	34
Exploration of the mechanism of 5-Methylcytosine promoting the progression of hepatocellular carcinoma	33
Single-cell insights into HNSCC tumor heterogeneity and programmed cell death pathways	32
Prognostication of colorectal cancer liver metastasis by CE-based radiomics and machine learning	32
Currents status of radiotracers for breast cancer imaging in PET	32
Multiphase enhanced CT-based transformer for differential diagnosis and predicting surgical risk events of solid abdominal tumors in children	31
Retinol-binding protein 4 as a promising serum biomarker for the diagnosis and prognosis of hepatocellular Carcinoma	31
YTHDF2 regulates the adriamycin (ADM) resistance in NKTCL by modulating the m6A modification of SLC16A9	31
Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer	30
Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models	30
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy	30
Glutamine withdrawal leads to the preferential activation of lipid metabolism in metastatic colorectal cancer	30
Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature	29
Liposomal sodium clodronate mitigates radiation-induced lung injury through macrophage depletion	29
E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting “E2F2/miR-16–5p/SPTLC1” schema	28
Intratumoral heterogeneity after targeted therapy in murine cancer models with differing degrees of malignancy	28
Matrix stiffness induces an invasive-dormant subpopulation via cGAS-STING axis in oral cancer	28
Nanoscale biomaterials for terahertz imaging: A non-invasive approach for early cancer detection	27
Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma	27
Acetophenone protection against cisplatin-induced end-organ damage	27
A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer	27
PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1	27
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma	26
Graphene therapy-related lncRNAs as prognostic and immune microenvironmental biomarkers in hepatocellular carcinoma	26
Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma	26
Bazedoxifene inhibits sustained STAT3 activation and increases survival in GBM	25
Parathyroid hormone related protein (PTHrP) in patients with pancreatic carcinoma and overt signs of disease progression and host tissue wasting	25
Nuclear protein in testis carcinoma of the lung	25
miR-362-3p suppresses ovarian cancer by inhibiting LRP8	25
Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer	25
CT radiomics combined with clinical variables for predicting the overall survival of hepatocellular carcinoma patients after hepatectomy	24
Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy	24
Selenium binding protein 1 inhibits tumor angiogenesis in colorectal cancers by blocking the Delta-like ligand 4/Notch1 signaling pathway	24
Amivantamab and Mobocertinib in Exon 20 insertions EGFR Mutant Lung Cancer, Challenge To The Current Guidelines	24
Aberrant overexpression of m6A writer and reader genes in pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL)	23
Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma	23
M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma	23
Fractionated radiation therapy alters energy metabolism and induces cellular quiescence exit in patient-derived orthotopic xenograft models of high-grade glioma	23

The need for research targeting the link between occupational carcinogens and hepatopancreatobiliary cancers in Africa: A systematic review	23
Beyond first-line therapy: efficacy and safety outcomes of continuing immunotherapy in extensive stage small cell lung cancer after PD-L1 inhibitor progression	22
Generation of a competing endogenous RNA network and validation of BNIP1 expression in the lung of irradiated mice	22
Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia	22
Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis	22
Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach	22
Comprehensive investigation in oncogenic functions and immunological roles of NCBP2 and its validation in prostate cancer	21
Tumor-stroma contact ratio - a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer	21
Uncarboxylated osteocalcin induced miR-143-3p targets SP7 and activates PI3K/Akt signaling in TNBC cells to promote invasion and migration	21
Single-cell RNA sequencing integrated with bulk RNA sequencing analysis of clock circadian regulator with prognostic and immune microenvironment in thyroid cancer	21
RIPK2 and lysosomal pathway: Unveiling a new mechanism for lung cancer metastasis	21
Expression of MASTL (Greatwall) associates with good prognosis and response to radiotherapy in pharyngeal squamous cell carcinoma	21
LncRNA TCL6 regulates miR-876–5p/MYL2 axis to suppress breast cancer progression	20
Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomach	20
Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in cervical cancer	20
HSP90AA1 is an unfavorable prognostic factor for hepatocellular carcinoma and contributes to tumorigenesis and chemotherapy resistance	20
HIF1A predicts the efficacy of anti-PD-1 therapy in advanced clear cell renal cell carcinoma	20
ENO1 promotes PDAC progression by inhibiting CD8+ T cell infiltration through upregulating PD-L1 expression via HIF-1α signaling	20
A clinical study on the efficacy of concurrent chemoradiotherapy combined with targeted therapy and hyperthermia in patients with locally advanced cervical cancer	20
Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer	20
Hub genes in adenocarcinoma of the esophagogastric junction based on weighted gene co-expression network analysis and immunohistochemistry	19
Integration of OV6 expression and CD68+ tumor-associated macrophages with clinical features better predicts the prognosis of patients with hepatocellular carcinoma	19
Comment on 'Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression' by Chen et al.'”	19
poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells	19
Identification of leucine-rich repeat-containing protein 59 (LRRC59) located in the endoplasmic reticulum as a novel prognostic factor for urothelial carcinoma	19
CKAP4-mediated activation of FOXM1 via phosphorylation pathways regulates malignant behavior of glioblastoma cells	19
Invasive phenotype in triple negative breast cancer is inhibited by blocking SIN3A–PF1 interaction through KLF9 mediated repression of ITGA6 and ITGB1	19
A pan-cancer landscape of centromere proteins in tumorigenesis and anticancer drug sensitivity	19
Cancer is not a guest	19
Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins	19
Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes	19
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy	19
The relationship between URG4 and clinicopathologic parameters and its effect on two-year survival in gastric carcinoma	19
LncRNA PSMB8-AS1 increases glioma malignancy via the miR-382-3p/BCAT1 axis	18
Spatial correlation between in vivo imaging and immunohistochemical biomarkers: A methodological study	18
Enhancement of Prognostic Outcomes in Stage III Non-Small Cell Lung Cancer: A Retrospective Study on Neoadjuvant Immuno-Chemotherapy Followed by Definitive Chemo-Radiotherapy	18
IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response	18
Patient reported change in pain outcome among stage IV cancer patients with bone metastases following palliative radiotherapy: A prospective study from Ethiopia	18
RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability and expression	18
Radiosensitizing effects of CDK4/6 inhibitors in hormone receptor-positive and HER2-negative breast cancer mediated downregulation of DNA repair mechanism and NF-κB-signaling pathway	18
Exosomal circ50547 as a potential marker and promotor of gastric cancer progression via miR-217/HNF1B axis	18
GTF2H5 Identified as a crucial synthetic lethal target to counteract chemoresistance in colorectal cancer	18
Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma	18
Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy	18
PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1α degradation	18
Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung Adenocarcinoma	18
Cardiotoxicity of breast cancer drug treatments	18
Multi-omics profiling to identify early plasma biomarkers in pre-diagnostic pancreatic ductal adenocarcinoma: a nested case-control study	17
Oncosuppressive role of MicroRNA-205–3p in gastric cancer through inhibition of proliferation and induction of senescence	17
Myoepithelial carcinoma of major salivary glands: Analysis of population-based clinicopathologic and prognostic features	17
Circular RNA 0010117 promotes aggressive glioblastoma behavior by regulating the miRNA-6779-5p/SPEN axis	17
Machine-learning based integrating bulk and single-cell RNA sequencing reveals the SLC38A5-CCL5 signaling as a promising target for clear cell renal cell carcinoma treatment	17
Progress on carbon dots and hydroxyapatite based biocompatible luminescent nanomaterials for cancer theranostics	17
The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity	17
Mechanisms of abemaciclib, a CDK4/6 inhibitor, induced apoptotic cell death in prostate cancer cells in vitro	17
Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth	17
Transition metal ion-doped ferrites nanoparticles for bioimaging and cancer therapy	17
INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment	17
High-resolution anoscopy predictive modeling of anal canal cancer response after definitive chemoradiotherapy in COVID19 era	17
NPRA promotes fatty acid metabolism and proliferation of gastric cancer cells by binding to PPARα	17
Low levels of miR-34c in nasal washings as a candidate marker of aggressive disease in wood and leather exposed workers with sinonasal intestinal-type adenocarcinomas (ITACs)	17
TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1	17
Circling back to epigenetic regulation in osteosarcoma: Comment on ‘Hsa_circ_0088212-mediated miR-520h/APOA1 axis inhibits the osteosarcoma progression’ by ‘ Hao Peng’	17
Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8+ T lymphocyte infiltration in human laryngeal squamous cell carcinoma	16
Yi Shen Tiao Gan decoction alleviates aromatase inhibitor–related bone loss by promoting H-type vessel formation	16
Sitravatinib combined with venetoclax exerts effective synergy to eliminate acute myeloid leukemia cells with FLT3-ITD mutations	16
Dysregulation of peripheral and intratumoral KLRG1+ CD8+ T cells is associated with immune evasion in patients with non-small-cell lung cancer	16
Development and validation of a prognostic and drug sensitivity model for gastric cancer utilizing telomere-related genes	16
Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy	16
Identification and validation of a prognostic risk model based on radiosensitivity-related genes in nasopharyngeal carcinoma	16
Integration RNA bulk and single cell RNA sequencing to explore the change of glycolysis-related immune microenvironment and construct prognostic signature in head and neck squamous cell carcinoma	16
Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging	16
Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma	15
USP8 regulates liver cancer progression via the inhibition of TRAF6-mediated signal for NF-κB activation and autophagy induction by TLR4	15
Lipid metabolism of clear cell renal cell carcinoma predicts survival and affects intratumoral CD8 T cells	15
Characterization of the mechanism of Scutellaria baicalensis on reversing radio-resistance in colorectal cancer	15
Long non-coding RNA FENDRR suppresses cancer-associated fibroblasts and serves as a prognostic indicator in colorectal cancer	15
Specific vaginal and gut microbiome and the anti-tumor effect of butyrate in cervical cancer women	15
Enhanced effect of radiofrequency ablation on HCC by siRNA-PD-L1-endostatin Co-expression plasmid delivered	15
A retrospective cohort study of neoadjuvant chemoradiotherapy combined with immune checkpoint inhibitors in locally advanced rectal cancer	15

A Commentary on: Long-term outcomes of induction chemotherapy followed by intensity modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease	15
Development and validation of a microenvironment-related prognostic model for hepatocellular carcinoma patients based on histone deacetylase family	15
lncRNA JPX modulates malignant progress of osteosarcoma through targeting miR-33a-5p and PNMA1 regulatory loop	15
Dysregulated proton and sodium gradients highlight cancer invasion and proliferation	15
Exploring the tumor-suppressive role of miRNA-200c in head and neck squamous cell carcinoma: Potential and mechanisms of exosome-mediated delivery for therapeutic applications	15
Individualized tumor-reactive T cells exhibit a potent anti-tumor response in prostate cancer	15
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles	15
TRPC5 mediates TMZ resistance in TMZ-resistant glioblastoma cells via NFATc3-P-gp pathway	15
Anti-cancer effects of pyrazole-platinum(II) complexes combined with anti-MUC1 monoclonal antibody versus monotherapy in DLD-1 and HT-29 colon cancer cells	15
LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma	15
Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signaling	15
A mini-review-cancer energy reprogramming on drug resistance and immune response	15
Transcriptional regulation of DLGAP5 by AR suppresses p53 signaling and inhibits CD8+ T cell infiltration in triple-negative breast cancer	15
Corrigendum to < Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience><Translational Oncology, 26C (2022) 10	15
Understanding the heterogeneity of pancreatic ductal adenocarcinoma	15
A high-quality model for predicting the prognosis of breast neuroendocrine carcinoma to help clinicians decide on appropriate treatment methods: A population-based analysis	14
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase	14
Comprehensive analysis of protein post-translational modifications reveals PTPN2-STAT1-AOX axis-mediated tumor progression in hepatocellular carcinomas	14
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3	14
Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion	14
Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids	14
CCR9-CCL25 mediated plasmacytoid dendritic cell homing and contributed the immunosuppressive microenvironment in gastric cancer	14
The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin	14
The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma	14
HER2 as a potential therapeutic target on quiescent prostate cancer cells	14
Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with chemoradiotherapy for induction chemotherapy resistant locally advanced nasopharyngeal carcinoma: A prospective phase II	14
Predicting oncogene mutations of lung cancer using deep learning and histopathologic features on whole-slide images	14
miRNA patterns in male LUSC patients - the 3-way mirror: Tissue, plasma and exosomes	14
Comprehensive assessment of serum 3′-tRFArg as a novel diagnostic biomarker for gastric cancer	14
Identification of novel prognostic indicators for oral squamous cell carcinoma based on proteomics and metabolomics	14
Prolactin enhances T regulatory cell promotion of breast cancer through the long form prolactin receptor	14
Analysis of transition metal content in glioblastoma reveals association between iron and survival	14
Distinctive mesenchymal-like neurofibroma stem cells shape NF1 clinical phenotypes controlled by BDNF microenvironment	14
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers	14
Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context	14
Circ-0008536 inhibits doxorubicin resistance in triple-negative breast cancer via the miR-382-5p/GGNBP2 axis	14
Exosomal mRNA Cargo are biomarkers of tumor and immune cell populations in pediatric osteosarcoma	14
Response Gene to Complement 32 is associated with poor patient survival and an inflamed tumor-immune microenvironment in clear cell renal cell carcinoma	14
Genomic profile helps to predict the clonal evolution and outcome of BCR-ABL-negative myeloproliferative neoplasms	14
Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma	14
PIS as a regulator of cellular heterogeneity, prognostic significance, and immune landscape in thyroid cancer	14
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients	13
Corrigendum to “Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells” [Translational Oncology 27 (2023) 1–9/101564]	13
RPL36A activates ERK pathway and promotes colorectal cancer growth	13
RPS21 Enhances hepatocellular carcinoma development through GPX4 stabilization	13
Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix	13
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade	13
Therapeutic effects of an innovative BS-HH-002 drug on pancreatic cancer cells via induction of complete MCL-1 degradation	13
Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice	13
RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification	13
Diversity and inclusivity in oncology: A narrative review and orientation for institutional measures in Germany	13
Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways	13
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma	13
Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care	13
ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma	13
Tebentafusp in first-line melanoma trials: An outperforming outlier	13
The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis	13
Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction	13
Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer	13
A comprehensive review on recent advances in exosome isolation and characterization: Toward clinical applications	13
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors	13
NDUFS8 facilitates hepatocellular carcinoma growth by enhancing mitochondrial function and escaping HUWE1-dependent degradation	13
Resonance of fatty acid metabolism and immune infiltration in anti-PD-1 monotherapy for breast cancer	13
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer	13
Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer	13
Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer	13
Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on ferroptosis-related genes and its association with immune infiltration	13
Early onset pancreatic cancer: A review	13
Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma	13
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection	13
Long noncoding RNA BBOX1-AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1	12
SNF5, a core subunit of SWI/SNF complex, regulates melanoma cancer cell growth, metastasis, and immune escape in response to matrix stiffness	12
FGF9/FGFR1 promotes cell proliferation, epithelial-mesenchymal transition, M2 macrophage infiltration and liver metastasis of lung cancer	12
Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience	12
NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-β in endometrial cancer	12
EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia	12
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review	12
Suppression of FAM83D Inhibits Glioma Proliferation, Invasion and Migration by Regulating the AKT/mTOR Signaling Pathway	12
Peripheral blood values as predictors of autoimmune status in oral cavity squamous cell carcinoma	12
PARP inhibitors and metastatic castration-resistant prostate cancer: uture directions and pitfalls	12
Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulation	12
Hypoxia induced cell dormancy of salivary adenoid cystic carcinoma through miR-922/DEC2 axis	12
Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p/EIF5A2 pathway	12
A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer	12
A role for androgen receptor variant 7 in sensitivity to therapy: Involvement of IGFBP-2 and FOXA1	12
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation	12
Radiotherapy: Brightness and darkness in the era of immunotherapy	12
Lithium chloride induces apoptosis by activating endoplasmic reticulum stress in pancreatic cancer	12
PTBP3 promotes tumorigenesis of glioblastoma by stabilizing Twist1	12
KIAA1529 regulates RAD51 expression to confer PARP inhibitors resistance in ovarian cancer	12
HADH suppresses clear cell renal cell carcinoma progression through reduced NRF2-dependent glutathione synthesis	11
Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model	11
GLI2-HRD1 axis facilitates 5-FU resistance in gastric cancer cells by regulating ubiquitination degradation of UCK2	11
Corrigendum to “PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor” [Volume 14, Issue 9, S	11
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer	11